-
Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01 Matthew D Solomon,Eve F Zaritsky,Margaret Warton,Andrea Millman,Ashley Huynh,Bharathi Chinnakotla,Mary E Reed
OBJECTIVE To investigate the effects of the Affordable Care Act (ACA) and its elimination of cost-sharing on contraception utilization, pregnancy rates, and abortion rates. METHODS We conducted a retrospective cohort study within a healthcare system serving over 4.5 million insured members across 21 medical centers and 250 clinics. The study included women aged 18-45 with continuous health plan membership
-
Trends in Urinary Tract Infection Management in Women. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Ghanshyam S Yadav,Heidi W Brown,Shawn A Menefee,Su-Jau Yang,Jasmine Tan-Kim
Urinary tract infections (UTIs) are a common cause of health care utilization in the United States. The coronavirus disease 2019 (COVID-19) pandemic accelerated virtual care for UTIs. This retrospective cohort study analyzes more than 1.2 million encounters for UTI based on diagnosis codes, examining temporal trends focusing on virtual compared with in-person encounters, antibiotic dispensation rates
-
Challenging the American College of Obstetricians and Gynecologists' Clinical Practice Update on Screening for Pre-existing Diabetes and Early Gestational Diabetes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Kent D Heyborne,Linda A Barbour
A recent American College of Obstetricians and Gynecologists Clinical Practice Update continues to recommend targeted (as opposed to universal) screening for pregestational diabetes, no longer recommends screening for early gestational diabetes mellitus (GDM), and provides updated guidelines for immediate postpartum testing for diabetes in patients with GDM. Here, we present data that the targeted
-
Development of a Practical Prediction Model for Adverse Neonatal Outcomes at the Start of the Second Stage of Labor. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Mark A Clapp,Siguo Li,Kaitlyn E James,Emily S Reiff,Sarah E Little,Thomas H McCoy,Roy H Perlis,Anjali J Kaimal
OBJECTIVE To develop a prediction model for adverse neonatal outcomes using electronic fetal monitoring (EFM) interpretation data and other relevant clinical information known at the start of the second stage of labor. METHODS This was a retrospective cohort study of individuals who labored and delivered at two academic medical centers between July 2016 and June 2020. Individuals were included if they
-
Effects of Social Determinants of Health and Social Support on Surgical Outcomes Among Patients Undergoing Hysterectomy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-31 Adam M Hare,Erryn Tappy,Joseph I Schaffer,Kelsey Kossl,Bertille Gaigbe-Togbe,Anjani Kapadia,Alexis A Dieter,Jennifer Hamner,Amanda K Laporte,Tsung Mou,Margaret G Mueller,Josephine Doo,Amy J Park,Graham C Chapman,Gina Northington,Marie Shockley,Cheryl B Iglesia,Michael Heit
OBJECTIVE To describe composite 30-day postoperative complication rates among patients undergoing hysterectomy during the coronavirus disease 2019 (COVID-19) pandemic and to determine baseline and postoperative mental health symptoms, levels of social support, and socioeconomic status and their association with hysterectomy outcomes. METHODS This multicenter prospective cohort study at eight centers
-
Effectiveness of the Intrauterine Balloon Tamponade Compared With an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device for Postpartum Hemorrhage. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Laurence E Shields,Catherine Klein,Jennie Torti,Mindy Foster,Curtis Cook
OBJECTIVE To compare intrauterine balloon tamponade and vacuum-induced hemorrhage-control devices in a multicenter hospital system using a standardized three-stage postpartum hemorrhage response algorithm. METHODS As part of a quality improvement project, data were prospectively collected through ongoing detailed hemorrhage case audits from 65 facilities from August 2022 to February 2024. Postpartum
-
Outcomes for Female Physicians Compared With Nonphysicians After Assisted Reproductive Technology. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Anna C Vanderhoff,Andrea Lanes,Rachel Herz-Roiphe,Keizra Mecklai,Oscar Leyva Camacho,Serene S Srouji,Sarah Rae Easter,Janis Fox,Erika L Rangel
OBJECTIVE To evaluate outcomes of female physicians after assisted reproductive technology (ART). METHODS We conducted a retrospective cohort study using data from 248 physician patients and 3,470 nonphysician patients who underwent a total of 10,095 fresh or frozen ART cycles at a single academic center in an insurance-mandated state between January 2015 and March 2022. The primary outcome was live-birth
-
Association of Central and General Obesity Measures With Pelvic Organ Prolapse. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Keyi Si,Yingying Yang,Qianqian Liu,Qin Wang,Shaohua Yin,Qingqiang Dai,Yuting Yao,Lei Yuan,Guizhu Wu
OBJECTIVE To examine the association between the combination of central and general obesity measures and the risk of pelvic organ prolapse (POP). METHODS Waist/height ratio and body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) for 251,143 participants (aged 39-71 years) without pre-existing POP from the UK Biobank were collected at enrollment between 2006
-
Changes in Availability of Later Abortion Care Before and After Dobbs v. Jackson Women's Health Organization. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-24 Nancy F Berglas,Rosalyn Schroeder,Shelly Kaller,Clara Stewart,Ushma D Upadhyay
OBJECTIVE To examine changes in availability of procedural abortion, especially in the second and third trimesters of pregnancy, since the U.S. Supreme Court ended federal protections for abortion in its Dobbs v. Jackson Women's Health Organization decision in 2022. METHODS We used the Advancing New Standards in Reproductive Health Abortion Facility Database, a national database of all publicly advertising
-
Addressing Social and Structural Determinants of Health in the Delivery of Reproductive Health Care: ACOG Committee Statement No. 11. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01
Social and structural determinants of health include historical, social, political, and economic forces, many of which are rooted in racism and inequality, that shape the relationship between environmental conditions and individual health. Unmet social needs can increase the risk of many conditions treated by obstetrician-gynecologists (ob-gyns), including, but not limited to, preterm birth, unintended
-
Symptom Resolution After Operative Management of Complications From Transvaginal Mesh: Notice of Update. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01
-
Diabetic Ketoacidosis in Pregnancy: A Call to Eliminate Preventable Complications. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-11-01 Chloe Zera
-
A Tribute to John T. Queenan, MD (1933-2024). Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-11 James R Scott
-
Age to Initiate Routine Breast Cancer Screening. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-11
This Clinical Practice Update provides revised guidance on the age to start routine breast cancer screening with mammography. This document is a focused update of related content in Practice Bulletin No. 179, Breast Cancer Risk Assessment and Screening in Average-Risk Women (Obstet Gynecol 2017;130:e1-16).
-
Combining Ultrasonography and Endometrial Aspiration as a One-Stop Screening for Endometrial Neoplasia. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-10 Ohad Rotenberg,Georgios Doulaveris,Gary L Goldberg,Malte Renz,Kathleen Whitney,Leeann Dar,Noam Rotenberg,Haotian Wu,Thierry Van den Bosch,Pe'er Dar
OBJECTIVE To assess the performance of simultaneous endometrial aspiration and sonohysterography to screen for endometrial cancer or hyperplasia in women aged 50 years or older. METHODS We conducted a prospective study from February 2014 to October 2020 at the ultrasound unit of a large urban academic medical center. The study included 1,635 women aged 50 years or older referred for endometrial evaluation
-
Betamethasone Exposure and Neonatal Respiratory Morbidity Among Late Preterm Births by Planned Mode of Delivery and Gestational Age. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-10 Mark A Clapp,Siguo Li,Jessica L Cohen,Cynthia Gyamfi-Bannerman,Amy B Knudsen,Scott A Lorch,Tanayott Thaweethai,Jason D Wright,Anjali J Kaimal,Alexander Melamed
OBJECTIVE To estimate the effect of late preterm antenatal steroids on the risk of respiratory morbidity among subgroups of patients on the basis of the planned mode of delivery and gestational age at presentation. METHODS This was a secondary analysis of the ALPS (Antenatal Late Preterm Steroid) Trial, a multicenter trial conducted within the Eunice Kennedy Shriver National Institute of Child Health
-
Late-Onset Postpartum Hypertension After Normotensive Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Colleen Sinnott,Lisbet Lundsberg,Jennifer Culhane,Caitlin Partridge,Anna E Denoble
To better inform efforts to improve and extend postpartum care, we sought to estimate the incidence of de novo hypertension up to 6 months postpartum in patients without evidence of hypertension during pregnancy or immediately postpartum. This retrospective cohort study included all patients delivering within an academic health care system. All blood pressure (BP) measurements from fertilization to
-
Screening Characteristics of Hemoglobin and Mean Corpuscular Volume for Detection of Iron Deficiency in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Hui Xiao Chao,Travis Zack,Andrew D Leavitt
Iron deficiency in pregnancy remains underdiagnosed despite professional society recommendations for first-trimester complete blood count (CBC) screening. To determine the effectiveness of the CBC hemoglobin and mean corpuscular volume (MCV) to identify iron deficiency in pregnancy, we conducted a retrospective analysis of 20,550 pregnancies from 2009 to 2022 at the University of California, San Francisco
-
A New Tool for Estimating the Number of Pregnant People in the United States. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Penelope Strid,Regina M Simeone,Rebecca Hall,Jessica R Meeker,Sascha R Ellington
BACKGROUND Knowing the approximate number of women of reproductive age (ie, 15-49 years) who are pregnant at a point in time in the United States can aid in emergency preparedness resource allocation. The Centers for Disease Control and Prevention (CDC) released a pregnancy estimator toolkit in 2012, which could be used to estimate the number of pregnant people in a geographic area at a point in time
-
Association Among Surgeon Volume, Surgical Approach, and Uterine Size for Hysterectomy for Benign Indications. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Sarah Santiago,Darington Richardson,Neil Kamdar,Sara R Till,Sawsan As-Sanie,Christopher X Hong
OBJECTIVE To assess the relationship between surgeon volume and surgical approach for patients undergoing hysterectomy for benign indications among uteri of varying sizes. METHODS This was a retrospective cohort study of patients who underwent hysterectomy for benign indications from 2012 to 2021 within the Michigan Surgical Quality Collaborative registry. For each hysterectomy, the relative annual
-
Sexual Orientation-Related Disparities in Neonatal Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-03 Payal Chakraborty,Colleen A Reynolds,Sarah McKetta,Kodiak R S Soled,Aimee K Huang,Brent Monseur,Jae Downing Corman,Juno Obedin-Maliver,A Heather Eliassen,Jorge E Chavarro,S Bryn Austin,Bethany Everett,Sebastien Haneuse,Brittany M Charlton
OBJECTIVE To evaluate whether disparities exist in adverse neonatal outcomes among the offspring of lesbian, gay, bisexual, and other sexually minoritized (LGB+) birthing people. METHODS We used longitudinal data from 1995 to 2017 from the Nurses' Health Study II, a cohort of nurses across the United States. We restricted analyses to those who reported live births (N=70,642) in the 2001 or 2009 lifetime
-
Updates in Prevention, Detection, and Management of Alloimmunized Pregnancies. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Teresa N Sparks,Kathryn J Gray
-
Excellent Performance of a Brief Self-Screening Tool for Medication Abortion Eligibility May Give Patients More Options. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Stephanie Teal
-
Oocyte Cryopreservation in Transgender and Gender-Diverse Individuals With or Without Prior Testosterone Use. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 Sarah Capelouto Cromack,Jessica R Walter,Kristin N Smith,Jennifer Elvikis,Sarah E Bazzetta,Kara N Goldman
To evaluate oocyte cryopreservation among transgender and gender-diverse adolescents and young adults with or without prior testosterone exposure, we performed a retrospective cohort study of all patients younger than age 35 years referred for oocyte cryopreservation through our formal fertility-preservation program from 2014 to 2023. The number of patients referred and pursuing fertility preservation
-
Second-Line Uterotonics for Uterine Atony: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 Naida M Cole,Jimin J Kim,Mario I Lumbreras-Marquez,Kara G Fields,Laura Mendez-Pino,Michaela K Farber,Daniela A Carusi,Paloma Toledo,Brian T Bateman
OBJECTIVE To evaluate the comparative efficacy of two of the most commonly used second-line uterotonics-methylergonovine maleate and carboprost tromethamine. METHODS We conducted a double-blind randomized trial at two large academic perinatal centers in patients undergoing nonemergency cesarean delivery with uterine atony refractory to oxytocin, as diagnosed by the operating obstetrician. The intervention
-
Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-26 David Viveros-Carreño,Nuria Agusti,Chi-Fang Wu,Alexander Melamed,Roni Nitecki Wilke,Alexa Kanbergs,René Pareja,Abigail S Zamorano,J Alejandro Rauh-Hain
OBJECTIVE To assess the effect on overall survival of simple hysterectomy with lymph node staging compared with radical hysterectomy with lymph node staging for patients with early-stage cervical cancer. METHODS We conducted a retrospective cohort study of patients in the National Cancer Database diagnosed with early cervical carcinoma of 2 cm or smaller (stage IA1 with lymphovascular space invasion
-
False-Positive Human Immunodeficiency Virus-1 Test Results With Rapid Seroreversion After Third-Trimester Tdap Booster Vaccination. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-13 Karl O A Yu,Seth R Glassman,Heather M Link
BACKGROUND False-positive and false-negative results in human immunodeficiency virus (HIV) testing are expected at some frequency. False-positive results have been reported in association with various conditions, including pregnancy, autoimmune disease, and infection. We present an atypical case of a pregnant patient receiving false-positive HIV results for both screening and antibody confirmatory
-
Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-10-01 Samantha L Martin,Hui-Chien Kuo,Kim Boggess,Lorraine Dugoff,Baha Sibai,Kirsten Lawrence,Brenna L Hughes,Joseph Bell,Kjersti Aagaard,Kelly S Gibson,David M Haas,Lauren Plante,Torri D Metz,Brian M Casey,Sean Esplin,Sherri Longo,Matthew Hoffman,George R Saade,Janelle Foroutan,Methodius G Tuuli,Michelle Y Owens,Hyagriv N Simhan,Heather A Frey,Todd Rosen,Anna Palatnik,Susan Baker,Phyllis August,Uma M Reddy
OBJECTIVE To compare differences in postpartum blood pressure (BP) control (BP below 140/90 mm Hg) for participants with hypertension randomized to receive antihypertensive treatment compared with no treatment during pregnancy. METHODS This study was a planned secondary analysis of a multicenter, open-label, randomized controlled trial (The CHAP [Chronic Hypertension and Pregnancy] trial). Pregnant
-
Tamsulosin and Time to Spontaneous Void After Hysterectomy: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-12 Martina Gabra,Christine Hall,Lelan McCann,Jeenal Shah,Ismael Jones,Aaron Masjedi,Stephanie Runke,Chiu-Hsieh Hsu,Andrea Aguirre
OBJECTIVE To evaluate whether a single preoperative dose of tamsulosin reduces the time to postoperative void and time to discharge in patients who are undergoing minimally invasive hysterectomy. METHODS This single-center, block-randomized, placebo-controlled, double-blind superiority trial evaluated the effect of 0.4 mg tamsulosin compared with placebo on the time to void after hysterectomy. Patients
-
Navigating the Legal Landscape of Reproductive Rights and Medical Training After LePage v. Mobile Infirmary Clinic. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-12 Alexandra Herweck,Ariana M Traub,Lisa M Shandley
-
Compliance Rate With Triage Test and Treatment for Participants Screening Positive in Cervical Cancer Screening Programs: A Systematic Review and Meta-analysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-12 Minmin Wang,Mailikezhati Maimaitiming,Yanxin Bi,Yinzi Jin
OBJECTIVE To assess the rates of adherence to triage testing after positive screening results and referral to treatment for precancerous lesions in global cervical cancer screening programs. DATA SOURCES We searched three electronic databases (Medline, EMBASE, and Web of Science) for articles published in the English language from January 1, 2018, to December 31, 2023. We included studies reporting
-
Management of Vulvovaginal Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-12 Erin E Ross,Rachel C Knapp,Marcia A Ciccone,Warren L Garner,T Justin Gillenwater,Haig A Yenikomshian
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is an autoimmune process resulting in painful epidermal sloughing that can involve the vulva and vagina. Current guideline recommendations are based on expert opinion and may not reflect modern management of SJS/TEN in burn centers. We performed a retrospective chart review of 34 female patients treated for SJS/TEN at our burn center
-
Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-10
This Clinical Practice Update provides revised guidance on Rh testing and Rh D immune globulin administration for individuals undergoing abortion or experiencing pregnancy loss at less than 12 0/7 weeks of gestation. This document updates Practice Bulletin No. 225, Medication Abortion Up to 70 Days of Gestation (Obstet Gynecol 2020;136:e31-47); Practice Bulletin No. 200, Early Pregnancy Loss (Obstet
-
Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-05 Maya Patel,Ashley N Battarbee,Jerrie S Refuerzo,Noelia Zork,Kacey Eichelberger,Gladys A Ramos,Gayle Olson,Celeste Durnwald,Mark B Landon,Kjersti M Aagaard,Kedra Wallace,Christina Scifres,Todd Rosen,Wadia Mulla,Amy Valent,Sherri Longo,Kim A Boggess
OBJECTIVE To estimate the association between maternal metformin use for the treatment of early gestational or pre-existing type 2 diabetes and preterm preeclampsia. METHODS This is a planned secondary analysis of the MOMPOD study (Medical Optimization of Management of Overt Type 2 Diabetes in Pregnancy), a randomized trial comparing the effect of adding metformin with insulin treatment on composite
-
Glycemic Control and Risk of Congenital Malformations in Women With Type 1 Diabetes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-05 Ida Holte Thorius,Janne Petersen,Lise Lotte N Husemoen,Amra C Alibegovic,Mari-Anne Gall,Peter Damm,Elisabeth R Mathiesen
OBJECTIVE To investigate the association between maternal glycemic control and the risk of congenital malformations in offspring of women with type 1 diabetes and to examine whether there is a hemoglobin A 1C (Hb A 1C ) threshold value at which the risk for malformations increases significantly. METHODS Analyses were performed on data from a multinational, observational cohort of 1,908 liveborn offspring
-
Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-30 Kelly C Young-Wolff,Felicia W Chi,Gwen T Lapham,Stacey E Alexeeff,Monique B Does,Deborah Ansley,Cynthia I Campbell
This population-based cross-sectional study analyzed electronic health record data of pregnant individuals in an integrated health care delivery system in California to examine changes in prenatal cannabis use through self-report and urine toxicology testing during standard prenatal care between 2012 (n=33,546) and 2022 (n=43,415), and to test whether trends differed by race and ethnicity or age. The
-
Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-30 Hunter J Wernick,Mahmoud Abdel-Rasoul,Elise D Berlan,Andrea E Bonny
OBJECTIVE To evaluate body mass index (BMI) over 36 months among adolescents and young adults using the etonogestrel implant compared with those using depot medroxyprogesterone acetate (DMPA) and a control group. METHODS We conducted a retrospective longitudinal cohort study of postmenarchal adolescents and young adults assigned female at birth. The etonogestrel implant and DMPA groups initiated etonogestrel
-
Treatment of Diabetes in Pregnancy With Metformin. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-29 Christine Newman,Fidelma P Dunne
Metformin is a commonly used drug in the treatment of type 2 diabetes and has been used to treat gestational diabetes since the 1970s. In pregnancy, its proven benefits include reduced gestational weight gain and reduced fetal size; some studies have shown reduced risk of cesarean delivery and lower rates of hypertension. Metformin can reduce the need for insulin therapy but does not eliminate such
-
Human Papillomavirus Vaccination in the Postpartum Period: A Systematic Review. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-29 Sara E Brenner,Susan Modesitt,Robert A Bednarczyk,Sarah E Dilley
OBJECTIVE To assess whether routine postpartum human papillomavirus (HPV) vaccination is acceptable and feasible and to identify key themes and strategies that can be used to increase postpartum HPV vaccination rates. DATA SOURCES PubMed and ClinicalTrials.gov were queried from inception to July 2024 for postpartum and HPV vaccination. Studies were limited to human subjects and the English language
-
Integrated Strategies to Support Diabetes Technology in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-29 Laura M Nally,Julia E Blanchette
Managing diabetes in pregnancy can be overwhelming, with numerous dramatic physiologic changes taking place that require constant diligence and attention. Advances in diabetes technology have improved glycemic outcomes, well-being, and quality of life for people with type 1 diabetes of all ages. However, regulatory approval and access to diabetes technology in pregnancy has lagged behind these advancements
-
Real-World Utilization of an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device: Correction. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-01
-
Minimizing Morbidity in Placenta Accreta Spectrum: A Balance of Risks. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-01 Jocelyn S Chapman,Arianna G Cassidy
-
Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-09-01 Paula M Castaño
-
Fellowship for Academic Generalists in Obstetrics and Gynecology: Is It Overdue? Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Alexandra M Abbate,Andrea K Knittel,David M Haas,Tiffany A Moore Simas,Lee A Learman,Jessica L Bienstock,Abimbola O Famuyide,Jeffrey F Peipert,Mostafa A Borahay
Academic specialists in general obstetrics and gynecology are clinicians practicing the full breadth of the specialty while also contributing to medical education and scientific discovery. Residency programs in obstetrics and gynecology provide exposure to research training that is variable but frequently limited. This creates challenges for junior faculty and in many cases limits their research productivity
-
Conservative Management of Placenta Accreta Spectrum and Breast-Milk Production. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Jennie Coselli,Elias Kassir,Katherine Lambert,Rylee Trotter,Baha Sibai,Pamela Berens
Conservative management of placenta accreta spectrum (PAS) includes delivery of the fetus with retention of the placenta in situ. There are insufficient data evaluating the effect of leaving the placenta in situ with PAS on the ability to establish lactation. We performed a prospective cohort study of 126 patients diagnosed with PAS. Clinical data pertaining to breastfeeding were obtained, as well
-
Correlation of Polycystic Ovarian Syndrome Phenotypes With Pregnancy and Neonatal Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Jessica L Chan,Richard S Legro,Esther Eisenberg,Margareta D Pisarska,Nanette Santoro
OBJECTIVE To compare pregnancy and neonatal outcomes in women with hyperandrogenic polycystic ovarian syndrome (PCOS) phenotypes compared with nonhyperandrogenic PCOS phenotypes. METHODS We conducted a retrospective cohort study of participants in the PPCOS (Pregnancy in Polycystic Ovary Syndrome) I and II randomized controlled trials; all of the participants met the National Institutes of Health diagnostic
-
Utility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers: A Systematic Review and Meta-analysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Murat Erden,Sonia Gayete-Lafuente,Nazli Aylin Vural,Kutluk H Oktay
OBJECTIVE To evaluate the utility, success, and safety of ovarian tissue cryopreservation and autologous cryopreserved ovarian tissue transplantation for fertility preservation in patients with gynecologic cancers. DATA SOURCES A comprehensive search was performed of the MEDLINE, EMBASE, ClinicalTrials.gov , and Cochrane Library databases to identify relevant studies on the utility and outcomes of
-
Pregnancy Outcomes in Patients With Hepatitis C Virus Infection. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Brenna L Hughes,Grecio J Sandoval,George R Saade,Rebecca G Clifton,Uma M Reddy,Anna Bartholomew,Ashley Salazar,Edward K Chien,Alan T N Tita,John M Thorp,Torri D Metz,Ronald J Wapner,Vishaka Sabharwal,Hyagriv N Simhan,Geeta K Swamy,Kent D Heyborne,Baha M Sibai,William A Grobman,Yasser Y El-Sayed,Brian M Casey,Samuel Parry,George A Macones,Mona Prasad,
OBJECTIVE To evaluate the risks of adverse maternal and neonatal outcomes associated with pregnancies complicated by hepatitis C virus (HCV) infection. METHODS This is a secondary analysis of a multicenter prospective cohort study of HCV infection in pregnancy. Participants were screened for HCV infection with serum antibody tests, and each participant with a positive HCV result (case group) was matched
-
Prenatal Care Utilization and Birth Outcomes After Expansion of the National Health Service Corps. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-22 Yanlei Ma,Olesya Baker,Fang Zhang,Carrie Cochran-McClain,Anjali J Kaimal,Hao Yu
OBJECTIVE The National Health Service Corps (NHSC) attracts clinicians to Health Professional Shortage Areas (HPSAs) through scholarships and loan repayments. Since 2009, the NHSC workforce, including maternity care clinicians, has substantially expanded. This study evaluates the association between NHSC expansion and prenatal care and birth outcomes. METHODS In this quasi-experimental study, we adopted
-
Barbed Sutures Compared With Conventional Sutures During Laparoscopic Myomectomy: A Systematic Review and Meta-analysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-15 Nikolaos Kathopoulis, Anastasia Prodromidou, Athanasios Douligeris, Michail Diakosavvas, Dimitrios Zacharakis, Konstantinos Kypriotis, Ioannis Chatzipapas, Themos Grigoriadis, Athanasios Protopapas
To accumulate the currently available literature on the safety and efficacy of the use of knotless barbed sutures for the reconstruction of the uterine wall during laparoscopic myomectomy based on comparison with traditional suture studies.
-
Management of Red Cell Alloimmunization in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-15 Kenneth J Moise, Elizabeth A Abels
Rhesus immune globulin has resulted in a marked decrease in the prevalence of RhD alloimmunization in pregnancy; however, antibody formation to other red cell antigens continues to occur. Evaluation for the presence of anti-red cell antibodies should be routinely undertaken at the first prenatal visit. If anti-red cell antibodies are detected, consideration of a consultation or referral to a maternal-fetal
-
Rising Stillbirth Rates Related to Congenital Syphilis in the United States From 2016 to 2022. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-15 Aliza Machefsky, Kaitlin Hufstetler, Laura Bachmann, Lindley Barbee, Kathryn Miele, Kevin O'Callaghan
To identify trends in stillbirth rates attributed to congenital syphilis in the United States by describing congenital syphilis-related stillbirths and comparing characteristics of pregnant people who had congenital syphilis-related stillbirths with those of people who had preterm and full-term liveborn neonates with congenital syphilis.
-
ACOG Committee Statement No. 10: Racial and Ethnic Inequities in Obstetrics and Gynecology. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-8-15
Disparate health outcomes and unequal access to care have long plagued many communities in the United States. Individual demographic characteristics, such as geography, income, education, and race, have been identified as critical factors when seeking to address inequitable health outcomes. To provide the best care possible, obstetrician-gynecologists should be keenly aware of the existence of and
-
Prenatal Care Clinician Preferences Among Patients With Spanish-Preferred Language. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-15 Haylie M Butler, Maria Bazan, Luis Rivera, Kevin E Salinas, Michele R Hacker, Sophia DeLevie-Orey, Molly R Siegel, Elysia Larson, Rose L Molina
To measure what patients with Spanish language preference and limited English proficiency value most when selecting a prenatal care clinician.
-
Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn: A Systematic Review. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-08 Ronan P Sugrue, Jaxon Olsen, Marie Elise Abi Antoun, Lesley A Skalla, Jennifer Cate, Andra H James, Alexandra Stonehill, Virginia Watkins, Marilyn J Telen, Jerome J Federspiel
To systematically review and meta-analyze alloimmunization among recipients of red blood cells (RBCs) matched for ABO blood type and Rhesus D (ABO+D) antigen compared with those also matched for c, E, and Kell (cEK).
-
Virtual Compared With In-Office Postoperative Visits After Urogynecologic Surgery: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-08 Lannah L Lua-Mailland, Amy S Nowacki, Marie Fidela R Paraiso, Amy J Park, Shannon L Wallace, Cecile A Ferrando
To compare patient satisfaction, health care resource utilization, and adverse events among patients receiving a virtual video compared with in-office postoperative visit after urogynecologic surgery. We hypothesized that virtual video visits would be noninferior to in-office visits.
-
Evaluation of Statewide Program to Reduce Cesarean Deliveries Among Nulliparous Individuals With Singleton Pregnancies at Term Gestation in Vertex Presentation. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-01 Melissa G Rosenstein,Shen-Chih Chang,Curisa M Tucker,Christa Sakowski,Stephanie A Leonard,Elliott K Main
OBJECTIVE To evaluate the effect of statewide efforts to reduce nulliparous, term, singleton, vertex (NTSV) cesarean delivery rates in California. METHODS This was a population-based study of all NTSV births in California from 2015 to 2019. In 2015, all California hospitals with NTSV cesarean delivery rates above the 23.9% Healthy People 2020 target were invited to join a CMQCC (California Maternal
-
-
Variables Associated With Resolution and Persistence of Ovarian Cysts: Correction. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-08-01
-